DBV:EPA
DBV Technologies SA
၁.၅၉ €
arrow_upward
+၁.၆၆%(+၀.၀၂၆) 1D
အောက် ၁၉, GMT+၂ ၁၇:၃၅:၀၆ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DBV...
Open
၁.၅၈ €
High
၁.၆၁ €
Low
၁.၅၃ €
Mkt. cap
၄၇.၃၄ ကုဋေ
Avg. vol.
၁.၁၁ သန်း
Volume
၁.၁၇ သန်း
52-wk high
၄.၅၀ €
52-wk low
၁.၅၃ €
EPS
-၀.၆၄ €
Shares outstanding
၃၁.၄၄ ကုဋေ
No. of employees
၁၇၀
Open
၁.၅၈ €
High
၁.၆၁ €
Low
၁.၅၃ €
Mkt. cap
၄၇.၃၄ ကုဋေ
Avg. vol.
၁.၁၁ သန်း
Volume
၁.၁၇ သန်း
52-wk high
၄.၅၀ €
52-wk low
၁.၅၃ €
EPS
-၀.၆၄ €
Shares outstanding
၃၁.၄၄ ကုဋေ
No. of employees
၁၇၀
News stories
From web sources and news partners
CBS News
·
ပြီးခဲ့သည့် ၁ နာရီ
Susan G. Komen Foundation rings opening bell at New York Stock Exchange
Stocktwits
·
ပြီးခဲ့သည့် ၃၁ မိနစ်
Nasdaq 100 Sees Best Day In Nearly A Month As AI Rout Cools — AMZN, BE, CRWV, AAPL, PLTR In Focus
FinancialContent
·
ပြီးခဲ့သည့် ၁ နာရီ
Zions Bancorporation (NASDAQ:ZION) Beats Q3 2026 EPS Estimates
Reuters
·
ပြီးခဲ့သည့် ၄ မိနစ်
Nasdaq climbs as chip and AI-linked stocks bounce back
Profile
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
About DBV Technologies SA